Amicus Therapeutics Statistics, Revenue Totals, Facts & News (2022)
Last Updated on: June 3rd, 2021
Here are a few of the most interesting Amicus Therapeutics statistics and facts I was able to dig up including revenue totals and employee counts. As always, be sure to check back in the future as I will be updating this post as new and updated stats become available.
Amicus Therapeutics Facts
- Website: Official Website
- Year Founded: 2002
- Headquarters: Cranbury, NJ
- Founder(s): John Crowley
- Current Chief Executive: John Crowley
What is Amicus Therapeutics?
We are a global, patient-dedicated biotechnology company focused on discovering, developing, and delivering high-quality medicines for people living with rare metabolic diseases. (source)
Amicus Therapeutics Employee Count
Number of Amicus Therapeutics employees:
Last updated 1/1/20
Amicus Therapeutics Revenue Totals
Amicus Therapeutics annual net product sales:
Amicus Therapeutics annual net income:
- 2019: $356 million net loss
- 2018: $348 million net loss
- 2017: $284 million net loss
- 2016: $200 million net loss
- 2015: $132 million net loss
Please note that some of these numbers are easier to find than others. A few of these Amicus Therapeutics stats come from their own reports, but some are based on news reports and not official company tallies. No information contained on DMR should be relied upon to make investment decisions. Basically, this is the best I can find and I don’t guarantee anything to be 100%.